The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm

European Neuropsychopharmacology

Volumn 24, Issue 7, 2014, Pages 1103-1111

  Rygula, Rafal ^a   Papciak, Justyna ^a   Popik, Piotr ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Ambiguous cue; Citalopram; Cognitive bias; D Amphetamine; Desipramine; Rat

Indexed keywords

CITALOPRAM; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE; LOMUSTINE; NORADRENALIN; SEROTONIN; ADRENERGIC RECEPTOR AFFECTING AGENT; DOPAMINE UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ACUTE DRUG ADMINISTRATION; AMBIGUOUS CUE; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; COGNITIVE BIAS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG RESPONSE; LATIN SQUARE DESIGN; LOW DRUG DOSE; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; ANIMAL; ANIMAL BEHAVIOR; COGNITION; DECISION MAKING; DISCRIMINATION LEARNING; DRUG EFFECTS; MOTOR ACTIVITY; SPRAGUE DAWLEY RAT;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; CITALOPRAM; COGNITION; CUES; DESIPRAMINE; DEXTROAMPHETAMINE; DISCRIMINATION LEARNING; DOPAMINE UPTAKE INHIBITORS; JUDGMENT; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 84902304138     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.01.012     Document Type: Article

References (60)

1. Adell A., Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 1991, 343:237-244.
2. Anderson M.H., Munafo M.R., Robinson E.S. Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task. Psychopharmacology (Berl) 2013, 226:601-613.
3. Artigas F., Romero L., de Montigny C., Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 1996, 19:378-383.
4. Bari A., Theobald D.E., Caprioli D., Mar A.C., Aidoo-Micah A., Dalley J.W., Robbins T.W. Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology 2010, 35:1290-1301.
5. Barton C.L., Hutson P.H. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Synapse 1999, 31:13-19.
6. Bateson M., Matheson S. Performance on a categorisation task suggests that removal of environmental enrichment induces 'pessimism' in captive European starlings (Sturnus vulgaris). Anim. Welfare 2007, 16(Suppl. 1):33-36.
7. Berridge C.W., Arnsten A.F., Foote S.L. Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models. Psychol. Med. 1993, 23:557-564.
8. Berridge C.W., Stratford T.L., Foote S.L., Kelley A.E. Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 1997, 27:230-241.
9. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 1996, 23:28-38.
10. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol. Psychiatry 2004, 55:1171-1178.
11. Bymaster F.P., Zhang W., Carter P.A., Shaw J., Chernet E., Phebus L., Wong D.T., Perry K.W. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl) 2002, 160:353-361.
12. Cardinal R.N., Robbins T.W., Everitt B.J. The effects of d-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology (Berl) 2000, 152:362-375.
13. Carlsson A., Lindqvist M. Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol 1978, 303:157-164.
14. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006, 311:861-863.
15. Chudasama Y., Nathwani F., Robbins T.W. d-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions. Behav. Brain Res. 2005, 158:97-107.
16. Cole B.J., Robbins T.W. Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology 1992, 7:129-142.
17. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12:31-40.
18. Cools R., Robinson O.J., Sahakian B. Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology 2008, 33:2291-2299.
19. Daw N.D., Kakade S., Dayan P. Opponent interactions between serotonin and dopamine. Neural Networks 2002, 15:603-616.
20. Dayan P., Huys Q.J. Serotonin in affective control. Annu. Rev. Neurosci. 2009, 32:95-126.
21. Deakin J.F., Graeff F.G. 5-HT and mechanisms of defence. J. Psychopharmacol. 1991, 5:305-315.
22. Doyle R.E., Lee C., Deiss V., Fisher A.D., Hinch G.N., Boissy A. Measuring judgement bias and emotional reactivity in sheep following long-term exposure to unpredictable and aversive events. Physiol. Behav. 2011, 102:503-510.
23. Drapier D., Bentue-Ferrer D., Laviolle B., Millet B., Allain H., Bourin M., Reymann J.M. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav. Brain Res. 2007, 176:202-209.
24. Enkel T., Gholizadeh D., von Bohlen Und Halbach O., Sanchis-Segura C., Hurlemann R., Spanagel R., Gass P., Vollmayr B. Ambiguous-cue interpretation is biased under stress- and depression-like states in rats. Neuropsychopharmacology 2010, 35:1008-1015.
25. Frank M.J., Seeberger L.C., O'Reilly R., C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004, 306:1940-1943.
26. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991, 41:1-24.
27. Hajos M., Gartside S.E., Sharp T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1995, 351:624-629.
28. Harding E.J., Paul E.S., Mendl M. Animal behaviour: cognitive bias and affective state. Nature 2004, 427:312.
29. Harmer C.J., O'Sullivan U., Favaron E., Massey-Chase R., Ayres R., Reinecke A., Goodwin G.M., Cowen P.J. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am. J. Psychiatry 2009, 166:1178-1184.
30. Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry 2004, 161:1256-1263.
31. Hjorth S., Auerbach S.B. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 1994, 260:251-255.
32. Howell D.C. Statistical Methods for Psychology 1997, Wadsworth, Belmont, California. fourth ed.
33. Hymel K.A., Sufka K.J. Pharmacological reversal of cognitive bias in the chick anxiety-depression model. Neuropharmacology 2012, 62:161-166.
34. Inoue T., Li X.B., Abekawa T., Kitaichi Y., Izumi T., Nakagawa S., Koyama T. Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur. J. Pharmacol. 2004, 497:311-316.
35. Invernizzi R., Belli S., Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 1992, 584:322-324.
36. Koch S., Perry K.W., Nelson D.L., Conway R.G., Threlkeld P.G., Bymaster F.P. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 2002, 27:949-959.
37. Lapiz M.D., Morilak D.A. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 2006, 137:1039-1049.
38. MacLeod A.K., Byrne A. Anxiety, depression, and the anticipation of future positive and negative experiences. J. Abnorm. Psychol. 1996, 105:286-289.
39. Matheson S.M., Asher L., Bateson M. Larger, enriched cages are associated with 'optimistic' response biases in captive European starlings (Sturnus vulgaris). App. Anim. Behav. Sci. 2008, 2008(109):374-383.
40. Mogg K., Baldwin D.S., Brodrick P., Bradley B.P. Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. Psychopharmacology (Berl) 2004, 176:466-470.
41. Morrison J.H., Molliver M.E., Grzanna R., Coyle J.T. The intra-cortical trajectory of the coeruleo-cortical projection in the rat: a tangentially organized cortical afferent. Neuroscience 1981, 6:139-158.
42. Nikiforuk A., Popik P. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Psychoneuroendocrinology 2011, 36:28-39.
43. Papciak J., Popik P., Fuchs E., Rygula R. Chronic psychosocial stress makes rats more 'pessimistic' in the ambiguous-cue interpretation paradigm. Behav. Brain Res. 2013, 256:305-310.
44. Pozzi L., Invernizzi R., Garavaglia C., Samanin R. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. J. Neurochem. 1999, 73:1051-1057.
45. Rygula R., Papciak J., Popik P. Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology 2013, 38:2188-2196.
46. Rygula R., Pluta H., Popik P. Laughing rats are optimistic. PLoS One 2012, 7:e51959.
47. Salmeto A.L., Hymel K.A., Carpenter E.C., Brilot B.O., Bateson M., Sufka K.J. Cognitive bias in the chick anxiety-depression model. Brain Res. 2011, 1373:124-130.
48. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 1965, 122:509-522.
49. Schultz W., Tremblay L., Hollerman J.R. Reward processing in primate orbitofrontal cortex and basal ganglia. Cerebral Cortex 2000, 10:272-284.
50. Seu E., Jentsch J.D. Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats. Neuropharmacology 2009, 57:665-672.
51. Sharot T., Guitart-Masip M., Korn C.W., Chowdhury R., Dolan R.J. How dopamine enhances an optimism bias in humans. Curr. Biol. 2012, 22:1477-1481.
52. Sharp T., Foster G.A. In vivo measurement using microdialysis of the release and metabolism of 5-hydroxytryptamine in raphe neurones grafted to the rat hippocampus. J. Neurochem. 1989, 53:303-306.
53. Sprouse J.S., Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1987, 1:3-9.
54. St Onge J.R., Floresco S.B. Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 2009, 34:681-697.
55. Stein A., Murphy S., Arteche A., Lehtonen A., Harvey A., Craske M.G., Harmer C. Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases. J. Psychopharmacol. 2012, 26:670-676.
56. Stutzmann G.E., LeDoux J.E. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J. Neurosci. 1999, 19:RC8.
57. van Gaalen M.M., van Koten R., Schoffelmeer A.N., Vanderschuren L.J. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol. Psychiatry 2006, 60:66-73.
58. Wade T.R., de Wit H., Richards J.B. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) 2000, 150:90-101.
59. Willner P., Scheel-Kruger J., Belzung C. The neurobiology of depression and antidepressant action. Neurosci. Biobehav. Rev 2012.
60. Wright W.F., Bower G.H. Mood effects on subjective probability assessment. Organ. Behav. Hum. Decis. Processes 1992, 276-291.